Esperion Therapeutics Inc (ESPR)
Accounts Payable
$68.41M
Quarterly · Period ending: · USD
ESPR Accounts Payable
Latest reported$68.41Mperiod ending
Latest reported$68.41Mperiod ending
ESPR Quarterly Accounts Payable ($1.04M → $68.41M)
Quarterly accounts payable
High-resolution chart · PNG
ESPR accounts payable history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Accounts Payable (USD) |
|---|---|
| 68,406,000 | |
| 65,068,000 | |
| 77,513,000 | |
| 74,704,000 | |
| 71,994,000 | |
| 51,650,000 | |
| 34,864,000 | |
| 47,669,000 | |
| 28,433,000 | |
| 31,718,000 | |
| 26,214,000 | |
| 24,558,000 | |
| 17,065,000 | |
| 23,040,000 | |
| 18,580,000 | |
| 12,832,000 | |
| 26,829,000 | |
| 17,559,000 | |
| 20,745,000 | |
| 29,353,000 | |
| 30,342,000 | |
| 51,975,000 | |
| 17,584,000 | |
| 29,690,000 | |
| 15,114,000 | |
| 28,856,000 | |
| 23,735,000 | |
| 28,404,000 | |
| 33,270,000 | |
| 44,893,000 | |
| 18,630,000 | |
| 22,482,000 | |
| 11,962,000 | |
| 20,375,000 | |
| 19,503,000 | |
| 18,714,000 | |
| 11,636,000 | |
| 4,595,000 | |
| 1,783,000 | |
| 1,566,000 | |
| 1,540,000 | |
| 707,000 | |
| 1,979,000 | |
| 3,305,000 | |
| 2,899,000 | |
| 2,040,000 | |
| 3,299,000 | |
| 4,211,000 | |
| 2,098,000 | |
| 2,232,000 | |
| 1,944,604 | |
| 1,655,762 | |
| 926,819 | |
| 476,277 | |
| 1,110,000 | |
| 1,389,000 | |
| 1,878,000 | |
| 1,687,000 | |
| 1,489,000 | |
| 2,282,000 | |
| 2,969,000 | |
| 2,925,000 | |
| 2,621,000 | |
| 1,409,000 | |
| 2,525,000 | |
| 3,936,000 | |
| 2,642,000 | |
| 1,143,000 | |
| 1,038,421 |